Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Filings indexed 1,095 across all filing types
Latest filing 2010-04-16 Director's Dealing
Country US United States of America
Listing US NVAX

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2010-04-16 English
4 Filing
Director's Dealing
2010-04-16 English
4 Filing
Director's Dealing
2010-04-16 English
4 Filing
Director's Dealing
2010-04-08 English
3 Filing
Director's Dealing
2010-04-08 English
8-K Filing
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 5, 2010, reporting the election of a new director, Dr. James F. Young, to the Board of Directors of Novavax, Inc. The key section is Item 5.02, which specifically addresses the departure or election of directors or officers. There is no financial data or detailed management discussion; the document is an announcement of a board management change. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2628 characters, which is consistent with a brief announcement rather than a full report.
2010-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.